6/20 IPMN showed a mutation in KRAS (G12R, G12V or G12D), 2/20 carried mutations at codon 201 of GNAS and 5/20 showed a mutation in TP53. Here, KRAS is linked to pancreatic intraductal papillary-mucinous neoplasm.